InvestorsHub Logo
icon url

DewDiligence

11/30/21 10:15 AM

#2108 RE: willyw #2107

AVIR’s COVID antiviral has already failed:

#msg-166797909
#msg-166425975
icon url

DewDiligence

11/30/21 10:17 AM

#2109 RE: willyw #2107

MRK's Molnupiravir is being evaluated by an FDA adcomm today:

icon url

vinmantoo

11/30/21 12:46 PM

#2114 RE: willyw #2107

Investing in a thinly traded stock is confounding.

This morning Merck is down for a few reasons
Moderna is down due to concerns about vaccine effectiveness against the new variant.
Pfizer is up (IMHO) due to faith in it's vaccines (relatively) but perhaps more so due to faith in it's covid antiviral (a PI)

Who else is up? AVIR at 8.06 this moment up 3%+ presumably an on hopes of it's Covid antiviral will work 225K shares traded.

And then there's ENTA which sat forever at -1.44 cents and 5800 shares traded.



You have to think of it as an investment opportunity. I do.